US Dental Industry Trends in 2026

US Dental Industry Trends in 2026

Written by

Ken Mah

in

,

2026 is a year of cautious recovery inside a long-running fiscal squeeze. Dentists are busier and more confident than a year ago, but dental spending is barely growing, costs are rising faster than reimbursement, hygienists remain nearly impossible to hire, and consolidation keeps advancing.

If you lead sales or marketing in the dental industry, that sentence should change how you plan the second half of the year. Below I walk through the seven forces shaping US dentistry in 2026, what each one does to dental labs, and the levers lab owners have to protect margin.

A note on sources: figures come mainly from HPI (the ADA Health Policy Institute) surveys and tracking, plus IBISWorld, BLS and CMS where noted.

Part 1: The state of US dentistry in 2026

1. Demand: busier chairs, flat dollars

Consumer dental spending in May 2026 was up just 1% from a year earlier and 11% above pre-pandemic levels (inflation-adjusted, about $216 billion annualized). Over ten years, spending on physician services is up 46% and health care overall is up 39%. Dental services are up only 24%.

Yet practices feel busier. In Q2 2026, around one in four dentists said they were not busy enough, down from previous quarters, and average new-patient wait times rose to 13.9 days.

HPI’s read on the disconnect: patient traffic may be rising, but for relatively low-value services, or dentists may be working harder for the same revenue.

A busy dentist is not necessarily a growing dentist.

2. Practice economics: the squeeze continues

Since January 2021:

  • Dental equipment and supply prices are up 23%
  • Hourly earnings of dental office staff are up 23%
  • The reimbursement rate index across all payers is up 19%, against 27% inflation

That is the defining structural problem of the year. Dentists are responding: 42% planned to add staff and 39% already have. 35% planned to drop some insurance networks and 24% have. And dentists have already surpassed their plans for new software investment.

Insurance is the top-cited concern for 2026, followed by staffing shortages and rising overhead.

3. Sentiment: recovering, but below 2024

In Q2 2026, dentists’ confidence in their practice, the dental sector and the US economy all rose versus the prior quarter, though it remains below late 2024. Half of dentists (50.2%) are confident in the dental sector and 25.2% are skeptical.

  • Top reason for confidence: dentistry is always needed (39.6%)
  • Top reason for skepticism: low reimbursement and insurance pressure (34.7%), with the rise of corporate dentistry and DSOs cited by 11%

Meanwhile, consumer sentiment sits at a historic low (University of Michigan index at 48.0), a warning sign for elective and cosmetic demand.

4. Workforce: hygienists are the bottleneck

Nearly 2 in 5 dentists were recruiting hygienists in Q2 2026, and 88% to 92% describe it as “very” or “extremely” challenging, a share that has hovered in that range for two years. Dental assistants are easier to hire: 68% report difficulty, down from 77% in early 2024.

Dental-office employment grew 1.5% over 12 months after two years of stagnation. HPI calls that a possible early sign that staffing issues are easing, but it is too soon to say. As of May 2026 there are 222,740 dental hygienists and 387,790 dental assistants working in the US.

5. AI crosses into the mainstream

The newest hard data point of the year: 43% of dentists now use AI for at least one task, most commonly imaging and diagnostics. Another quarter plan to adopt. Three in ten say they never will.

The line dentists won’t cross is treatment planning. Four out of five have no interest in AI making patient treatment recommendations. Planned 2026 adoption is heavily administrative: front-desk check-in, scheduling, practice analytics, charting and note-taking. Sentiment is mixed, with 21.5% generally optimistic and 13.8% opposed, and some comments cite radiograph AI that is “consistently wrong.”

6. Consolidation keeps advancing

DSO affiliation reached 16.1% of dentists in 2024, and over 1 in 4 early-career dentists. 69% of DSOs expect increased acquisitions in 2026, and the lab sector continues shrinking toward fewer, larger players.

The 2026 wrinkle is financial stress at the leveraged end, with restructurings at Dental Care Alliance and Affordable Care, alongside tightening state scrutiny such as California’s Aspen settlement.

7. Policy: headwinds for public coverage, tailwinds for insurer accountability

  • Medicaid: the federal budget law cut states’ Medicaid budgets, and most states will implement work-reporting requirements. Adult dental benefits are optional and often among the first items cut. Colorado is a live example: a $3,000 annual adult cap and an across-the-board 2% Medicaid rate cut effective July 1, 2026.
  • Marketplace: CMS reinstated the prohibition on treating routine adult dental services as an essential health benefit in Exchange plans, reversing a 2024 policy that would have let states include them from 2027.
  • Fluoride: a new wave of state legislation aims to restrict or ban community water fluoridation, following Utah and Florida.
  • Dental loss ratio (DLR): Massachusetts became the first state to enforce DLR standards, requiring six insurers to return $8.4 million to consumers. Mississippi enacted a reporting law, and bills are moving in New York, Idaho, Alabama and West Virginia. This is organized dentistry’s counterpunch to reimbursement pressure.
  • Federal: a Medicaid Dental Benefit Act of 2026 was introduced in the Senate to require adult coverage, but it sits in committee.

What to watch in the second half of 2026

  • Whether the Q2 busyness bump shows up as revenue in Q3 data
  • Whether dental-sector job growth continues, the first real test of hygienist supply
  • How many states cut adult Medicaid dental as budget years turn over
  • Whether DLR spreads beyond Massachusetts
  • Whether the DSO restructuring wave stays contained to two platforms or widens

Caveat: HPI’s panel (552 private-practice respondents in Q2) skews toward ADA-member, owner, solo or small-group, mid-to-late-career dentists in urban areas. DSO-employed and early-career perspectives are underweighted in the sentiment figures.

Part 2: What this means for dental labs

Mapped onto dental labs, the picture is mostly unfavorable for small independents and mixed-to-favorable for scaled, digital labs. Here is how each force plays through.

1. Flat spending plus busier dentists means volume without pricing power

Case counts may hold up, but the mix tilts toward cheaper units (single-unit zirconia, repairs, night guards) rather than high-margin cosmetic and full-arch work. With consumer sentiment at a historic low, elective and implant cases, where labs earn the most, are the first thing patients defer.

IBISWorld reports the US dental lab market has been essentially flat, with revenue growing only 0.1% a year between 2021 and 2026, and the pressure is likely to persist.

2. The fiscal squeeze gets passed downstream

When a dentist’s supply prices are up 23% and reimbursement is up 19%, the lab bill is the largest discretionary line they can attack. Expect three responses in 2026: harder price negotiation, more shopping between labs, and more offshoring.

Offshore labs already handle about 38% of restorations at up to 50% less than US labs. And the dentists dropping insurance networks are doing so precisely to protect margin, which leaves little room for higher lab fees.

3. Tariffs hit labs from the input side

Labs rely on imported zirconia, titanium components and specialized materials, and tariff-driven cost increases are trickling down to practices as higher lab fees. Reciprocal tariffs, with China rates up to 54% and relief unlikely before late 2026, create a squeeze within the squeeze: labs pay more for inputs but face customers who can’t absorb price increases.

One partial offset: tariffs also raise the landed cost of finished offshore crowns, narrowing the gap that has pulled work overseas for 20 years. Whether that repatriates any volume depends on whether tariffs outlast the current cycle.

4. DSO consolidation is the biggest structural threat

DSOs shift market power from independent offices to large, centralized groups, and a highly fragmented lab industry struggles to meet the resource and capital demands they impose. Concretely:

  • DSOs consolidate purchasing into one or two national contracts (Glidewell, National Dentex, Modern Dental), bypassing the local labs acquired practices used. Every practice a DSO buys is a customer a small lab is likely to lose within 12 to 24 months.
  • Larger DSOs are building in-house labs. Aspen, for instance, has long run centralized denture fabrication.
  • DSO financial stress cuts both ways: distressed DSOs squeeze vendors harder on price and payment terms, and a lab with one large DSO account faces real receivables risk.

5. Digital and AI accelerate the shakeout

Chairside milling and 3D printing let practices bypass labs entirely for simple cases. Remake rates below 1% for digital cases versus 3% to 4% for traditional impressions push dentists toward digitally equipped labs. AI design tools and 2026 direct-printed aligner technology reduce labor per unit.

Many small labs simply cannot afford scanners, CAD/CAM or printers, and in a low-growth year the capital gap widens. The 43% of dentists now using AI will increasingly expect labs to plug into digital workflows.

6. Workforce pressure is arguably worse for labs than for practices

The hygienist shortage gets the attention, but labs face a technician pipeline that has been shrinking for a decade. Only 17 accredited programs remained by 2016, BLS projects technician employment to decline 2% through 2035, and an aging workforce means retirements outpace entrants. Labs compete for the same limited pool as DSO in-house labs and equipment makers, with less ability to raise wages.

7. Policy: coverage cuts remove the low end

Medicaid adult dental cuts and the reinstated Marketplace ban matter less to labs than to practices, but they subtract denture and extraction-related volume in states like Colorado. Dental loss ratio laws, if they spread, could eventually lift reimbursement and ease pressure on lab fees, but that is a 2027-plus story.

Net effect by lab size

  • Sole proprietors and labs under 10 employees: the least able to invest in digital, the most exposed to DSO customer loss, and the hardest hit by material costs. Expect the decades-long attrition to continue or accelerate, largely through closure and sale to regional labs.
  • Regional labs (20 to 200 employees): the strategic middle. Those that go fully digital, specialize (implants, esthetics, sleep appliances) and diversify beyond one DSO client can absorb small-lab volume. Those that don’t become acquisition targets for the roll-ups.
  • National platforms (Glidewell, NDX, Modern Dental): best positioned. They gain DSO contracts, spread tariff and technology costs across volume, and can build offshore or nearshore capacity themselves.

Part 3: How labs can respond

Practical implications for a lab owner in 2026: lock in multi-year pricing with key accounts before tariffs fully flow through; diversify so no single DSO exceeds roughly 20% of revenue; treat digital intake as table stakes rather than a differentiator; and consider whether a strategic sale is better executed now, while multiples for digital labs remain reasonable, than after another year of flat demand.

Given the squeeze, the most effective levers either cut cost per unit or shift revenue toward work that offshore labs and chairside printers can’t easily take. Here they are, roughly in order of impact.

1. Digitize intake and design end to end

The single biggest productivity gain available. Each case that arrives as an intraoral scan rather than a physical impression skips pouring, trimming and shipping, and remake rates drop from 3% to 4% to under 1%. Subsidize or bundle scanner onboarding for top accounts, require digital submission for standard zirconia units, and use AI-assisted design software so one designer handles far more units per day. Measure “percent of cases digital at intake” monthly. Labs above 70% generally run materially lower labor per unit than those below 30%.

2. Rationalize the product mix and price by tier

Most labs carry too many SKUs and price them inconsistently. Group products into three tiers (economy, standard, premium or esthetic) with clear turnaround and material specs, and price each tier to its cost. Push commodity single-unit work to an automated workflow or an outsourced milling partner, and reserve skilled technician hours for implant, full-arch and esthetic cases that carry 2 to 3 times the margin. Reprice or retire any line that doesn’t cover its fully loaded cost, including remakes.

3. Attack remakes and rework directly

Remakes are the most expensive units a lab produces and are almost never priced in. Track remake rate by dentist, technician and product, then act on the outliers: coach chronically bad-impression accounts or move them to digital, standardize case-acceptance checks at intake, and set internal quality gates before finishing. Cutting remakes from 4% to 1.5% is worth several points of margin on its own.

4. Fix material purchasing before tariffs fully land

Zirconia, lithium disilicate, titanium and resins are the exposed inputs. Consolidate to fewer suppliers for volume pricing, negotiate forward contracts or fixed-price windows while suppliers are still competing for volume, standardize on two or three disc and block brands to cut inventory, and evaluate domestic or non-China sources for the highest-tariff items. Track material cost per unit as a KPI, not just total spend.

5. Selectively outsource, keep the finish

In the hybrid model, frameworks and simple units are milled or printed by a partner (domestic or offshore) while skilled staff do esthetic finishing and quality control. A small lab can offer a full catalog without the capital cost of every machine. The key is transparency with dentists about point of origin (required disclosure in several states) and keeping the client relationship and final quality in-house.

6. Restructure the customer base

Concentration is the hidden risk in 2026. Cap any DSO at roughly 20% of revenue, and price DSO contracts with volume tiers and payment terms that reflect their credit risk. Actively target practices that are dropping insurance networks and moving to fee-for-service: they are less price-sensitive and buy more premium work. Specialists (prosthodontists, oral surgeons, periodontists) are the highest-value accounts and the least likely to be swallowed by DSO purchasing.

7. Build scheduling and throughput discipline

Many labs run on tribal knowledge. A basic production-management system with case tracking, capacity scheduling and turnaround commitments by product tier reduces expediting, idle time and rush-fee waivers. Batch similar work (nesting multiple units per zirconia disc, running printers overnight) and stagger deadlines so equipment runs near capacity rather than in bursts.

8. Retain and multiply technicians

With the pipeline shrinking, losing a skilled ceramist costs more than any equipment. Cross-train so digital designers can finish and finishers can design, create clear pay ladders tied to skills and CDT certification, and use AI design and automated milling so each technician’s hours go to the highest-skill steps. An in-house apprenticeship is slow, but it is now the primary way to add capacity.

9. Add adjacent revenue that offshore labs can’t serve

Local turnaround and clinical proximity are the independent lab’s structural advantage. Sleep apnea appliances, night guards, surgical guides, same-week implant temporaries, aligner retention and chairside support for full-arch cases all favor a nearby partner. Some labs are also selling design services or milling capacity to smaller labs, converting excess machine hours into revenue.

10. Know your unit economics and review them quarterly

Most of the above fails without measurement. The minimum dashboard:

  • Revenue and gross margin per unit by product tier
  • Labor hours per unit
  • Remake rate
  • Digital-intake rate
  • Material cost per unit
  • Top-10 customer concentration
  • Turnaround-time adherence

A lab that knows these numbers can make pricing and investment decisions in weeks rather than discovering problems at year-end.

Part 4: Choosing outsourcing and technology partners

Most of the levers above depend on the same move: let a partner carry the capital-intensive steps so your skilled people can focus on finishing, quality and the client relationship. Here is how to evaluate partners against each lever, whichever vendors you are considering.

Selective outsourcing without offshoring (levers 5 and 9)

A domestic manufacturing partner can be an alternative to offshore outsourcing for commodity and framework work: milled zirconia units and bridges, custom abutments, 3D-printed models, milled metals, SLM copings, PMMA, wax, digital dentures, RPD frameworks, screw-retained bars and bridges, e.max and bite splints.

What to look for:

  • An FDA-registered, US-based facility, so you stay compliant with point-of-origin disclosure rules and can tell dentists where the work is made
  • Real production scale and uptime, not a handful of machines
  • Flexibility to serve both labs without mills and labs with mills that need overflow support, so the partner works as a capacity buffer during peaks or staff absences rather than an all-or-nothing switch

Reducing technician hours per unit (levers 1 and 8)

  • Outsourced design services (intraoral scan design and abutment design) let a lab take digital cases without hiring a dedicated CAD designer. Look for a 3D approval viewer, and the ability to download the design back into your own design software, adjust it, and release it for manufacturing.
  • Integrated, split-file production that manufactures the model, abutment and restoration together for consistent fit cuts assembly and adjustment time on implant cases.
  • Pre-shaded multilayer and gradient zirconia systems, ideally paired with a simple characterization workflow, let a technician go start to finish faster and reduce shade-matching variance.

Implant work as the high-margin specialty (lever 2)

Custom abutments are the most accessible entry point for labs that want more implant and full-arch volume without buying a five-axis mill and titanium stock. Ask for:

  • Five-axis milling and FDA 510(k) clearance
  • Multiple variants: titanium, screw-retained, CoCr SLM hybrid, PMMA and zirconia
  • Compatibility with the major implant systems your dentists place
  • Fast, defined turnaround (two days is a reasonable benchmark to ask about)

Bars, bridges and digital dentures from the same partner round out a full-arch offering, which is the work DSO purchasing and chairside printers are least likely to take.

Material cost and tariff exposure (lever 4)

Ask where a supplier’s zirconia discs are actually made. Domestic manufacturing reduces exposure to Chinese-sourced material tariffs, but raw zirconia powder is still globally sourced, so ask any supplier directly about their input supply chain.

Two other cash levers worth pursuing with suppliers:

  • Precious metal refining and scrap buyback. In a year when gold is expensive, systematically returning alloy grindings, old crowns and casting scrap is one of the few pure cash levers a lab has.
  • Inventory management and vendor consolidation. Tools that attack overstocking and shrinkage in the supply room, and suppliers that can cover general lab supplies, simplify purchasing.

Remake reduction and throughput (levers 3 and 7)

The mechanisms that matter:

  • A 3D design approval step that catches design errors before manufacturing
  • Model-plus-restoration production from a single scan
  • Standardized pre-shaded materials
  • Training sessions on design software and technique, which help with intake quality
  • Order settings with global preferences and posted manufacturing cut-off times, so you can build the partner’s turnaround into your own scheduling and promise dentists implant restorations on a defined timeline

Where a partner fits less well

  • A partner doesn’t solve customer concentration or DSO contract risk. That is your commercial strategy, not a vendor’s.
  • A manufacturing partner is not production-tracking or practice-management software.
  • If your plan is to build a large in-house digital center, a partner becomes a materials supplier rather than a manufacturing partner.
  • Outsourcing centers compete with each other and with the large labs themselves, some of which make their own zirconia and equipment. Benchmark unit pricing and turnaround against at least one alternative.

A practical sequence

  1. Start with custom abutments and zirconia milling overflow to free technician hours immediately.
  2. Add outsourced design services to accept more digital intake without a new hire.
  3. Standardize on one or two zirconia disc lines to simplify inventory and shade management, and set up scrap refining.
  4. Evaluate digital dentures and full-arch bars as the specialty growth line.

Questions to ask any prospective partner

  • Where is the work made, and how do you support point-of-origin disclosure?
  • What are your turnaround commitments and cut-off times by product?
  • How does the design approval and round-trip workflow work with my design software?
  • What is your remake policy and remake rate?
  • Where do your discs, blocks and powders come from, and how are you handling tariffs?
  • What is your pricing by product tier, and how does it compare with the alternative I am benchmarking?

Confirm current pricing and turnaround commitments in writing before you commit volume.

The bottom line

Dentistry in 2026 is busy but not booming, and the squeeze lands hardest on whoever sits at the end of the supply chain. For labs, the winners will be the ones that digitize intake, price by tier, protect against DSO concentration, and own the work that offshore labs and chairside printers can’t easily take.

Which of these forces is hitting your business hardest right now?

Resources and sources

Links to the original data and reporting behind the figures above, grouped by topic. Where a figure comes from an ADA Health Policy Institute (HPI) report, I have linked both the HPI page and trade-press coverage that summarizes it.

Demand, practice economics, sentiment and staffing

AI adoption

DSO consolidation and financial stress

Policy

Dental lab industry

More posts